Clinical Trial Update: Pilot Randomized Study of RD-X19 Tx Device in Subjects With PCC (Long Covid) in the Outpatient Setting [NA]

View source ↗

Summary

A pilot randomized trial evaluating the RD-X19 Tx Device for Post-acute sequelae of SARS-CoV-2 infection (long COVID) in outpatients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• RD-X19 Tx Device

Snippet

Sponsor: EmitBio Inc. | Conditions: Post COVID-19 Condition (PCC) | NA | Status: TERMINATED